FDA Approval Insights: Subcutaneous Daratumumab in Multiple Myeloma
Season 3, Episode 5, May 21, 2020, 06:58 PM
We had the pleasure of speaking with Maria-Victoria Mateos, MD, PhD, to discuss the FDA approval of the subcutaneous daratumumab formulation in multiple myeloma.